Recursion Pharmaceuticals, Inc. (RXRX)
4.12
+0.05
(+1.23%)
USD |
NASDAQ |
Oct 02, 16:00
4.12
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Market Cap : 2.201B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.201B |
| October 01, 2026 | 2.174B |
| September 30, 2026 | 2.206B |
| September 29, 2026 | 2.153B |
| September 28, 2026 | 1.976B |
| September 25, 2026 | 1.998B |
| September 24, 2026 | 2.078B |
| September 23, 2026 | 1.976B |
| September 22, 2026 | 2.163B |
| September 21, 2026 | 2.120B |
| September 18, 2026 | 2.046B |
| September 17, 2026 | 1.891B |
| September 16, 2026 | 1.704B |
| September 15, 2026 | 1.731B |
| September 14, 2026 | 1.821B |
| September 11, 2026 | 1.709B |
| September 10, 2026 | 1.688B |
| September 09, 2026 | 1.717B |
| September 08, 2026 | 1.837B |
| September 04, 2026 | 1.939B |
| September 03, 2026 | 1.837B |
| September 02, 2026 | 1.805B |
| September 01, 2026 | 1.779B |
| August 31, 2026 | 1.816B |
| August 28, 2026 | 1.784B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.837B |
| August 26, 2026 | 1.864B |
| August 25, 2026 | 1.901B |
| August 24, 2026 | 1.736B |
| August 21, 2026 | 1.869B |
| August 20, 2026 | 1.784B |
| August 19, 2026 | 1.869B |
| August 18, 2026 | 1.650B |
| August 17, 2026 | 1.661B |
| August 14, 2026 | 1.688B |
| August 13, 2026 | 1.768B |
| August 12, 2026 | 1.757B |
| August 11, 2026 | 1.789B |
| August 10, 2026 | 1.757B |
| August 07, 2026 | 1.720B |
| August 06, 2026 | 1.699B |
| August 05, 2026 | 1.693B |
| August 04, 2026 | 1.768B |
| August 03, 2026 | 1.699B |
| July 31, 2026 | 1.592B |
| July 30, 2026 | 1.613B |
| July 29, 2026 | 1.576B |
| July 28, 2026 | 1.618B |
| July 27, 2026 | 1.597B |
| July 24, 2026 | 1.571B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Editas Medicine, Inc. | 402.25M |
| Amgen, Inc. | 217.88B |
| Halozyme Therapeutics, Inc. | 12.53B |
| Novavax, Inc. | 1.724B |
| AVITA Medical, Inc. | 393.39M |
Market Cap Related Metrics
| PS Ratio | 38.22 |
| Price to Book Value | 2.405 |
| Price | 4.12 |
| Earnings Yield | -25.15% |